JUPW - Jupiter Wellness sponsors SPAC Jupiter Wellness Acquisition targeting AI medical therapeutics and diagnostics

Jupiter Wellness (JUPW +2.8%) files a registration statement with the SEC to sponsor Jupiter Wellness Acquisition (JWACU), a SPAC, dedicated to investing in AI based therapeutics and diagnostics with an initial funding target of $100M. Company has finalized the recruitment and on-boarding of its board of directors and aims to be listed on the Nasdaq. Medical applications of AI hold significant promise to improve clinical care and offer massive new commercial opportunities as the healthcare AI market is projected to reach $36B by 2025. "We've assembled a board that combines extensive experience in healthcare and finance. Our medical team has a successful history in drug development and AI along with deep relationships with medical centers and regulatory bodies in the U.S. and Europe. The finance team brings a wealth of transactional experience including M&A, equity and debt financing, and IPOs. We're actively targeting companies in the healthcare AI space with enterprise values between $300 million

For further details see:

Jupiter Wellness sponsors SPAC, Jupiter Wellness Acquisition targeting AI medical therapeutics and diagnostics